| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.riddhisiddhi.co.in | |
| Market Cap | 240.45 Cr. | |
| Enterprise Value(EV) | 406.79 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -4.67 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 64.78 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 2,133.79 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 0.16 | Calculated using Price: 336.30 |
| Dividend Yield | 0.30 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.71 Cr. | 7,129,786 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Riddhi Siddhi Gluco Biols is the one of innovation and adventure, of risks taken and bold decisions made. The seeds of this successful corporate conglomerate were sown in 1990 in the name of Riddhi Siddhi Chemicals Pvt Ltd. In March 1992 the name was changed to Riddhi Siddhi Chemicals Ltd. What followed was an unmatched series of innovations, achievements and accolades. | ||
| 1 Day |
|
-3.89% |
| 1 Week |
|
-5.45% |
| 1 Month |
|
-7.86% |
| 3 Month |
|
-6.48% |
| 6 Month |
|
-2.86% |
| 1 Year |
|
-24.19% |
| 2 Year |
|
+25.07% |
| 5 Year |
|
-57.44% |
| 10 Year |
|
+15.97% |
| 7 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 3.21 | -3.37 | 0.65 | 4.76 | 1.68 | -4.30 | 0.15 | |
| Return on Capital Employed (%) | 5.08 | 1.64 | 1.64 | 6.17 | 3.53 | 0.47 | 2.25 | |
| Return on Assets (%) | 2.12 | -2.04 | 0.39 | 3.20 | 1.20 | -3.17 | 0.12 |
| Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 1,367 | 1,323 | 1,389 | 1,436 | 1,425 | 1,453 | 1,504 | 1,521 | |
| Non Curr. Liab. | 254 | 232 | 169 | 108 | 61 | 96 | 90 | 85 | |
| Curr. Liab. | 347 | 640 | 416 | 357 | 340 | 292 | 156 | 148 | |
| Minority Int. | 107 | 178 | 168 | 165 | 133 | 99 | 87 | 85 | |
| Equity & Liab. | 2,075 | 2,373 | 2,142 | 2,066 | 1,959 | 1,941 | 1,838 | 1,839 | |
| Non Curr. Assets | 952 | 1,026 | 1,072 | 1,131 | 976 | 1,341 | 1,298 | 1,286 | |
| Curr. Assets | 1,123 | 1,347 | 1,070 | 935 | 983 | 600 | 539 | 553 | |
| Misc. Exp. not W/O | |||||||||
| Total Assets | 2,075 | 2,373 | 2,142 | 2,066 | 1,959 | 1,941 | 1,838 | 1,839 |
| Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
| Net Sales | 342 | 508 | 804 | 682 | 576 | 498 | 521 | 277 | |
| Other Income | 134 | 118 | 335 | 70 | 50 | 59 | 64 | 66 | |
| Total Income | 476 | 626 | 1,139 | 752 | 627 | 557 | 585 | 343 | |
| Total Expenditure | -349 | -560 | -1,073 | -605 | -529 | -511 | -511 | -275 | |
| PBIDT | 127 | 66 | 66 | 147 | 98 | 45 | 74 | 68 | |
| Interest | -33 | -52 | -62 | -40 | -31 | -26 | -20 | -17 | |
| Depreciation | -35 | -35 | -34 | -35 | -37 | -37 | -37 | -36 | |
| Taxation | -15 | -25 | 39 | -6 | -6 | -44 | -16 | -26 | |
| Exceptional Items | |||||||||
| PAT | 44 | -45 | 9 | 67 | 24 | -62 | 2 | -11 | |
| Minority Interest | -4 | 3 | 10 | -19 | 9 | 15 | 12 | 8 | |
| Share Associate | |||||||||
| Other Related Items | |||||||||
| Consolidated Net Profit | 40 | -43 | 19 | 49 | 33 | -47 | 14 | -3 | |
| Adjusted EPS | 56 | -60 | 27 | 68 | 46 | -66 | 20 | -5 |
| Particulars | 7 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | -284 | -34 | -1 | 116 | 130 | 161 | |
| Cash Fr. Inv. | -67 | 65 | 269 | 163 | 30 | -91 | -71 | |
| Cash Fr. Finan. | -55 | 192 | -263 | -169 | -131 | -108 | -94 | |
| Net Change | -122 | -27 | -28 | -7 | 15 | -69 | -3 | |
| Cash & Cash Eqvt | 2 | 4 | 1 | 1 | 32 | 3 | 0 |
|
Sat, 31 Dec 2022
Closure of Trading Window Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 as amended and in compliance with the terms of Code of Conduct of the Company we hereby inform you that Trading Window for dealing in the securities of the Company will be closed for all Designated Persons and their immediate relatives from 1st January 2023 and the same will remain closed till expiry of 48 hours after public announcement of Unaudited Financial Results of the Company for the quarter ended 31st December 2022 (both days inclusive).Accordingly all designated persons and their immediate relatives of the Company have been advised not to trade in the securities of the Company during the above mentioned period of closure of window.You are requested to take a note of the same |
|
Mon, 28 Nov 2022
Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (LODR) Regulations 2015 For The Half Year Ended 30Th September 2022 Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby submit disclosure on related party transactions for the half year ended 30th September 2022. |
|
Mon, 14 Nov 2022
Results- Financial Results For Sep 30 2022 (Standalone And Consolidated) Pursuant to Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 ("Listing Regulations") we hereby inform you that the Board of Directors of the Company has inter alia approved Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended on 30th September 2022 along with Limited Review Reports issued by the Statutory Auditor M/s Batliboi & Purohit Chartered Accountants Mumbai (FRN: 101048W). Copy of the same is annexed herewith. |
| Fri, 27 Jan 2023 |
Higher Trade Quantity
|
Close Crossing Last Week Low
|
Close Crossing Last Month Low
|
Closing Below Previous Low
|
Making Lower Lows for 3 days
|
Equities
M.F.
Sectors